Preemptive Analgesic Effects of Rectus Sheath Block in Laparoscopic Cholecystectomy Patients
Primary Purpose
Preemptive Peripheral Nerve Block, Pain, Postoperative, Acute Pain
Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Ultrasound guided Rectus sheath block
Intercostal nerve block
Sponsored by
About this trial
This is an interventional prevention trial for Preemptive Peripheral Nerve Block focused on measuring preemptive analgic effect, Rectus Sheath Block, laparoscopic cholecystectomy
Eligibility Criteria
Inclusion Criteria:
- adults between the ages of 20 and 80
- scheduled laparoscopic cholecystectomy patient
- ASA class 1 or 2
- Patients who have voluntarily agreed in writing to participate in the trial
Exclusion Criteria:
- Patient with side effects on local anesthetics or steroids
- Patient who are taboo of peripheral nerve block such as blood clotting disorder, infection, etc.
- Patients with uncontrolled medical or psychiatric problem
- Patient does not agree to participate in the study
- Patients who are pregnant or lactating
- Patients whose visceral pain is expected to be too severe
- Patients receiving a single laparoscopic cholecystectomy (including using a robot)
Sites / Locations
- Asan Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
preoperative Rectus sheath block: group Pre
postoperative Rectus sheath block: group Post
Arm Description
ultrasound guided Rectus sheath block block with 0.25% ropivacaine 40ml Before surgical incision
ultrasound guided Rectus sheath block block with 0.25% ropivacaine 40ml After surgical incision
Outcomes
Primary Outcome Measures
Difference of analgesic consumption between both group
The difference in analgesics usage between the two groups after the operation is checked at fixed intervals (at 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operation) to compare.
Secondary Outcome Measures
compare the Numeric rating scale (NRS)
The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older.
0: No pain, 1-3: mild pain, 4-6: Moderate pain, 7-10: severe pain, 10: worst pain imaginable.
After surgery, the NRS differences between the two groups were compared at a constant interval (0, 0.5, 1, 2, 6, 9, 18, 24 hours postoperatively).
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03413280
Brief Title
Preemptive Analgesic Effects of Rectus Sheath Block in Laparoscopic Cholecystectomy Patients
Official Title
The Effectiveness of Preemptive Effect of Rectus Sheath Block and Intercostal Block on Postoperative Visceral Pain in Laparoscopic Cholecystectomy
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
March 28, 2017 (Actual)
Primary Completion Date
August 25, 2017 (Actual)
Study Completion Date
January 15, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Asan Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The purpose of this study was to investigate the effectiveness of preemptive effect of rectus sheath block (RSB) and intercostal nerve block (ICNB) on postoperative visceral pain in laparoscopic cholecystectomy (LLC).
After induction of general anesthesia, group of patient is decided randomly. In Group pre, RSB and ICNB are performed with 0.25% Ropivacaine 40ml before the operation. In Group post, RSB and ICNB are performed with 0.25% Ropivacaine 40ml after the operation.
Measure the NRS and compare the rescue analgesic dose used at 0, 0.5, 1, 2, 6, 9, 18, and 24 hours after arrival at the recovery room.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preemptive Peripheral Nerve Block, Pain, Postoperative, Acute Pain
Keywords
preemptive analgic effect, Rectus Sheath Block, laparoscopic cholecystectomy
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Actual)
8. Arms, Groups, and Interventions
Arm Title
preoperative Rectus sheath block: group Pre
Arm Type
Experimental
Arm Description
ultrasound guided Rectus sheath block block with 0.25% ropivacaine 40ml Before surgical incision
Arm Title
postoperative Rectus sheath block: group Post
Arm Type
Active Comparator
Arm Description
ultrasound guided Rectus sheath block block with 0.25% ropivacaine 40ml After surgical incision
Intervention Type
Drug
Intervention Name(s)
Ultrasound guided Rectus sheath block
Intervention Description
Ultrasound guided rectus sheath block with 0.25% ropivacaine 34ml around umbilicus
Intervention Type
Drug
Intervention Name(s)
Intercostal nerve block
Intervention Description
Ultrasound guided intercostal nerve block with 0.25% ropivacaine 6ml in 7,8,9 th intercostal space
Primary Outcome Measure Information:
Title
Difference of analgesic consumption between both group
Description
The difference in analgesics usage between the two groups after the operation is checked at fixed intervals (at 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operation) to compare.
Time Frame
at 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operation
Secondary Outcome Measure Information:
Title
compare the Numeric rating scale (NRS)
Description
The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older.
0: No pain, 1-3: mild pain, 4-6: Moderate pain, 7-10: severe pain, 10: worst pain imaginable.
After surgery, the NRS differences between the two groups were compared at a constant interval (0, 0.5, 1, 2, 6, 9, 18, 24 hours postoperatively).
Time Frame
at 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
adults between the ages of 20 and 80
scheduled laparoscopic cholecystectomy patient
ASA class 1 or 2
Patients who have voluntarily agreed in writing to participate in the trial
Exclusion Criteria:
Patient with side effects on local anesthetics or steroids
Patient who are taboo of peripheral nerve block such as blood clotting disorder, infection, etc.
Patients with uncontrolled medical or psychiatric problem
Patient does not agree to participate in the study
Patients who are pregnant or lactating
Patients whose visceral pain is expected to be too severe
Patients receiving a single laparoscopic cholecystectomy (including using a robot)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
JongHyuk Lee, MD
Organizational Affiliation
Asan Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Asan Medical Center
City
Seoul
State/Province
Songpa-gu
ZIP/Postal Code
05505
Country
Korea, Republic of
12. IPD Sharing Statement
Learn more about this trial
Preemptive Analgesic Effects of Rectus Sheath Block in Laparoscopic Cholecystectomy Patients
We'll reach out to this number within 24 hrs